Desmopressin
Performance & EnduranceSynthetic vasopressin analog used for diabetes insipidus, bedwetting, and hemophilia.
Key Benefits
- ✓Reduces excessive urination
- ✓Treats bedwetting
- ✓Helps hemophilia A patients
- ✓Reduces nighttime urination
- ✓Water retention for athletic weight-making (misuse)
Dosing Information
Detailed Protocol
Administered intranasally, orally, or via injection depending on indication. For bedwetting, typically one dose at bedtime. For diabetes insipidus, dosed 2-3 times daily.
About Desmopressin
Desmopressin (DDAVP) is a synthetic analog of vasopressin (antidiuretic hormone) with enhanced antidiuretic effects and reduced vasopressor activity. FDA-approved for diabetes insipidus, primary nocturnal enuresis (bedwetting), and hemophilia A. Also used off-label for nocturia.
Research Notes
FDA-approved with extensive clinical use for multiple indications. Well-established efficacy and safety profile when used appropriately with sodium monitoring.
Potential Side Effects
- •Water retention
- •Hyponatremia (low sodium) risk
- •Headache
- •Nausea
- •Requires monitoring
Always consult with a healthcare professional before starting any peptide therapy.